FACTS ABOUT INTERLEUKIN-2 MECHANISM OF ACTION REVEALED

Just one point mutation, V6A, released into the molecule drastically enhanced the toxicity profile and reduced VLS when compared with the WT molecule [76]. Additional experiments and medical trials are going to be needed to ascertain if this modified build has enhanced basic safety and efficacy in humans.Tregs: T regulatory cells; TME: tumor microe